Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae

BACKGROUND: Most KPC-producing organisms have maintained susceptibility to polymyxins; however, development of resistance to polymyxins has been increasingly reported. One potential treatment modality is to optimize the use of combination therapy. Therefore, we evaluated the in vitro activity of dor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Grace C., Burgess, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601507/
https://www.ncbi.nlm.nih.gov/pubmed/23519391
http://dx.doi.org/10.4021/jocmr1220w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601507/
https://www.ncbi.nlm.nih.gov/pubmed/23519391
http://dx.doi.org/10.4021/jocmr1220w

Ejemplares similares